Blood components and plasma derived blood products can save lives and provide clinical benefit to many patients if appropriately used.
If blood components are likely to be indicated, transfusion should not be a default decision. Instead, the decision on whether to transfuse should be carefully considered, talking into account the full range of available therapies, and balancing the evidence for efficacy and improved clinical outcome against the potential risks.(1)
To assist with your decision we recommend reference to the Transfusion checklist and the National Blood Authority Patient Blood Management Guidelines. The decision to transfuse is a prescribing doctor’s responsibility.
As the prescribing clinician, you should ensure that blood component therapy is given only when clearly indicated. In addition, make sure your patient is monitored during the transfusion.
Read the use of specific blood components:
Always remember that successful and safe transfusion practice depends on administering a quality blood component of the right type, in the right amount, in the right way, at the right time to the right patient.